Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity i… (NCT07375797) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes
Denmark16 participantsStarted 2026-02-05
Plain-language summary
The purpose of the trial is to investigate the effect of fecal microbiota transplantation versus placebo on glycemic metabolism and gut microbiota composition in people with type 2 diabetes.
Who can participate
Age range18 Years – 67 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Has type 2 diabetes
Exclusion Criteria:
* Treatment with insulin or sulfonylurea drugs.
* Treatment with antibiotics, probiotics/lactic acids cultures, or proton pump inhibitors within the last three months.
* Regular exercise and/or more than 150 minutes of moderate intensity exercise or 75 minutes of high intensity exercise per week, within the last 6 months.
* Diagnosed with unstable angina, recent (within the last 8 weeks) myocardial infarction, any disease in the coronal arteries, decompensated heart failure (NYHA II-IV), severe valvular disease, lung disease
* Hypertension which is not currently under medical control (systolic pressure \>200 mmHg and/or diastolic pressure \>130 mmHg)
* Bariatric surgery within the previous year or a plan to undergo bariatric surgery during the study period
* Self-reported drug or alcohol abuse
* Patients preparing for or currently experiencing pregnancy during the study period
* Disease of the liver and/or gallbladder, including parenchymal liver disease, liver cirrhosis, pancreatitis, autoimmune liver disease
* All diseases of the gastrointestinal tract, which can lead to or increase the risk of defects in the mucosal membrane. This includes chronic diarrhea, inflammatory bowel disease, malabsorption, malnutrition, recent infection with clostridium difficile, primary sclerosing cholangitis, radiation induced enteritis, chemotherapy induced diarrhea, hematological diseases
* Reactive hypoglycemia
* Anemia and ot…